CTTI would like to welcome our three newest members: Life Raft, the MPN Research Foundation, and the Foundation for Prader-Willi Research.

Life Raft provides support through information, education, and innovative research to patients with a rare cancer called GIST (Gastrointestinal Stromal Tumor). Executive Director Norman Scherzer will represent this organization on CTTI’s Steering Committee.

The MPN Research Foundation works to stimulate original research in pursuit of new treatments for myeloproliferative neoplasms (MPN). Deputy Director Michelle Woehrle will represent this organization on CTTI’s Steering Committee.

The Foundation for Prader-Willi Research works to eliminate the challenges of the genetic disorder known as the Prader-Willi syndrome through the advancement of research. Director of Research Programs Theresa Strong will represent for this organization on CTTI’s Steering Committee.

As patient groups, these organizations represent one of many key stakeholders that CTTI engages to collaboratively improve the quality and efficiency of the clinical trials enterprise. For more information about CTTI’s organizational structure, including the Steering Committee, CLICK HERE.